Casey Yoder, a representative from Myriad Neuroscience, will discuss the GeneSight® Psychotropic test. This genetic test analyzes gene variations that may impact how a patient metabolizes and responds to certain psychiatric medications. The results of the test may provide information about which medications may require dose adjustments, may be less likely to work, or may have an increased risk of side effects based on patient’s genetic makeup.
Read more about the test at GeneSight® Psychotropic test.
